Cargando…
Potentiation of ghrelin signaling attenuates cancer anorexia–cachexia and prolongs survival
Cancer anorexia–cachexia syndrome is characterized by decreased food intake, weight loss, muscle tissue wasting and psychological distress, and this syndrome is a major source of increased morbidity and mortality in cancer patients. This study aimed to clarify the gut–brain peptides involved in the...
Autores principales: | Fujitsuka, N, Asakawa, A, Uezono, Y, Minami, K, Yamaguchi, T, Niijima, A, Yada, T, Maejima, Y, Sedbazar, U, Sakai, T, Hattori, T, Kase, Y, Inui, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309517/ https://www.ncbi.nlm.nih.gov/pubmed/22832525 http://dx.doi.org/10.1038/tp.2011.25 |
Ejemplares similares
-
Rikkunshito, a ghrelin potentiator, ameliorates anorexia–cachexia syndrome
por: Fujitsuka, Naoki, et al.
Publicado: (2014) -
Increased ghrelin signaling prolongs survival in mouse models of human aging through activation of sirtuin1
por: Fujitsuka, N, et al.
Publicado: (2016) -
Plasma Ghrelin Levels Are Associated with Anorexia but Not Cachexia in Patients with NSCLC
por: Blauwhoff-Buskermolen, Susanne, et al.
Publicado: (2017) -
Ghrelin for cachexia
por: Akamizu, Takashi, et al.
Publicado: (2010) -
Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile
por: Pietra, Claudio, et al.
Publicado: (2014)